Numinus Wellness
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Numinus Wellness generated cash of -$22,760,068, which is more than the previous year. Cash used in financing activities reached the amount of -$1,458,312 last year. Net change in cash is therefore -$24,464,509.
Cash Flow
| 2017 | -249.68K | -39.43K | 245.96K |
|---|---|---|---|
| 2019 | -3.76M | -752.82K | 4.46M |
| 2020 | -5.35M | -128.69K | 7.02M |
| 2021 | -15.57M | -739.24K | 73.98M |
| 2022 | -26.22M | 123.19K | 7.34K |
| 2023 | -22.76M | -369.56K | -1.45M |
NUMI.TO Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 33.04M | 59.29M | 1.62M | 89.98K | 141.97K | 111.82K |
Operating activities | ||||||
Net income | -30.25M | -44.88M | -18.77M | -9.60M | -7.26M | -259.64K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 2.83M | 1.50M | 716.99K | 613.41K | 539.45K | 253 |
Stock-based compensation expense | 1.86M | 3.45M | 1.82M | 1.87M | 1.95M | 0 |
| Deferred income tax benefit | 1.86M | 3.45M | 1.82M | 1.87M | 1.95M | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -1.32M | 98.13K | -127.83K | -172.53K | -107.97K | -7.22K |
Inventories | -176.98K | -359.63K | -3.23K | 1.40K | -266.51K | 0 |
Accounts payable | 176.98K | 46.35K | -665.88K | 203.35K | 716.36K | 0 |
Cash generated by operating activities | -22.76M | -26.22M | -15.57M | -5.35M | -3.76M | -249.68K |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -375.45K | -1.24M | -641.96K | -35.20K | -874.60K | 0 |
Acquisitions Net | 0 | 1.36M | -401.79K | -93.49K | 0 | 0 |
Cash generated by investing activities | -369.56K | 123.19K | -739.24K | -128.69K | -752.82K | -39.43K |
Financing activities | ||||||
Common Stock Issued | 915.99K | 691.82K | 74.31M | 6.13M | 1.26M | 245.96K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -2.37M | -684.48K | -334.31K | -398.43K | -187.40K | 0 |
Cash used in financing activities | -1.45M | 7.34K | 73.98M | 7.02M | 4.46M | 245.96K |
Net Change In Cash | -24.46M | -26.24M | 57.66M | 1.53M | -51.98K | -43.15K |
Cash at end of period | 8.57M | 33.04M | 59.29M | 1.62M | 89.98K | 68.66K |
| Data source | Data source | Data source | Data source | Data source | Data source |